Chronic HIV-1 infection induces severe immune alterations, including hyperactivation, exhaustion and apoptosis. In fact, viral control has been associated with low frequencies of these processes. Here, we evaluated the expression of activation and inhibitory molecules on NK and CD4 + T-cells in individuals exhibiting viral control: a cohort of HIV-1-exposed-seronegative individuals (HESN) and a cohort of HIV-controllers. There was lower expression of CD69, LAG-3, PD-1 and TIM-3 in both cohorts when compared to a low-risk population or HIV-progressors. These findings suggest that individuals exhibiting viral control have lower basal expression of markers associated with cellular activation and particularly immune exhaustion. 
Similar to other pathogens, exposure to human immunodeficiency virus type-1 (HIV-1) does not always result in infection. In fact, there are individuals who have been repeatedly exposed to HIV-1 but do not exhibit clinical or serological evidence of infection, who are known as HIV-1-exposed seronegative individuals (HESN) 1 . One of the most recently proposed models to explain HESN is the immune quiescence phenotype, which is characterized by a low baseline immune activation that reduces HIV target cell availability, as was previously reported [3] [4] [5] . In addition, several studies indicate that NK and CD4 + T-cells play an important role in controlling or inhibiting viral replication, not only for their direct antiviral activity, but also for their interaction with other immune cells [6] [7] [8] [9] .
However, when the HIV-1 infection is established, the virus induces severe alterations in the gut associated lymphoid tissue, favoring microbial translocation from the intestinal lumen to systemic circulation, inducing a persistent state of immune activation 10 . This state is characterized by expression of activation markers on immune cells, including T and NK cells, as well as high circulating levels of pro-inflammatory cytokines, such as IP-10 and TNF- 11, 12 . During HIV-1 infection the persistent inflammatory environment finally triggers the immune exhaustion phenomenon, favoring alterations of CD4 + T-cell functions, decreases in cytokines, and low cytotoxic activity of NK and CD8+ T cells 13, 14 . The molecules CD69, PD-1 (programmed-death 1), Tim-3 (T-cell immunoglobulin domain and mucin domain-3) and LAG-3 (lymphocyteactivation gene-3), associated with activation and exhaustion states, alter the anti-viral immune response modulating the susceptibility to HIV-1 infection and progression 15, 16 . Interesting, clinical evolution of HIV-1 infected individuals is variable, as there individuals as HIV-controllers who exhibit a spontaneous and sustained control of viral replication (<2000 copies/mL) at least for one year in the absence of antiretroviral therapy 2 .
HESN and HIV-controllers are very interesting cohorts, as their characterization might give insights into mechanisms associated with viral control. We hypothesize that HESN and HIV-controllers exhibit a lower basal expression of activation and inhibitory molecules on CD4 + T-cells and NK cells, as well as lower levels of plasma pro-inflammatory cytokines, when compared to low-risk or HIV-progressor individuals, respectively. This study was conducted to [24] [25] [26] . Using microarray assays, it was demonstrated that HESN exhibit a low level of expression in genes encoding activation molecules, suggesting a quiescent cellular state 27, 28 .
These data supports our observation of low expression of CD69 on NK cells in HESNs. Low activated immune cells are less prompted to become infected and less susceptible to produce viral particles [3] [4] [5] .
There is limited information on the relevance of the expression of inhibitory molecules during HIV-1 exposure. One study reported that dendritic cells and monocytes exposed in vitro to HIV-1 showed a significant increase in PD-1 ligand (PD-L1) expression, which in consequence reduced the response of the interacting T cells 29, 30 , suggesting that during HIV-1 exposure the basal expression of inhibitory molecules could be influencing the immune response, therefore the establishment of the infection.
The lower expression of inhibitory molecules on immune cells from HESNs could be an intrinsic consequence of their lower expression of activation molecules, as it has been previously shown, in order to be able to become effector cells when needed 28 . This is supported by reports showing that despite the low level of expression of activation molecules, HESNs are able to mount an effective immune response upon stimulation 27 . Alternatively, HESNs could have genetically low baseline levels of activation/inhibitory molecules associated to polymorphisms in genes encoding for these proteins. Indeed, generic variations have been reported in PD-1, Tim-3 and CTLA-4 genes that can modulate the baseline expression of these molecules [31] [32] [33] . Interesting, the minor G allele at rs4704846 in the gene that encodes Tim-3 (HAVCR2), was more common in HIV-1 infected individuals than in HESN. This variation increases the expression of HAVCR2, and most likely reduces the response against HIV-1 during exposure 34 . However, one study reported a high expression of Tim-3 in mature NK cells that responded efficiently after the stimulation with cytokines 35 . This somehow contrasting data underlines the requirement of further studies exploring the role of these molecules during the viral challenge.
On the other hand, in HIV-1-infected patients, negative regulators of the immune response are associated to AIDS progression, as well as an inflammatory environment and immune activation 15, 36 . In fact, the expression of HLA-DR and CD38 on CD4 + and CD8 + T cells is currently proposed as predictors of AIDS, as their expression indicates immune hyperactivation 36 . In this sense, the expression of inhibitory molecules has been related with low production of cytokines and cytotoxic molecules, like IFN- and perforin 37 . In fact, the expression of PD-1, CTLA-4, LAG-3 and Tim-3 is positively correlated to viral load and negatively to CD4 + T cell counts [38] [39] [40] [41] . Supporting these previous evidences we found that HIV-controllers exhibited lower expression of activation and inhibitory molecules along with lower production of proinflammatory cytokines, compared to HIV-progressors. Previous studies in HIV-controllers suggest that the early control of viral replication is mediated by different effector mechanisms, including: i) increased HIV-specific IL-21+ CD4 + T-cell responses, associated with optimal cytotoxic responses mediated by CD8 + T-cells 42 ; ii) greater cytolytic activity of HIV-specific CD8 + T-cells, mainly directed to cells expressing different Gag epitopes 43 ; iii) effective production of cytokines and cytotoxic response of NK cells 44 : iv) higher HIV-specific neutralizing antibody responses 45 ; and v) increased expression of soluble antiviral proteins 46 . It seems that in HIV-1 controllers, low viral replication over time is a key factor to maintain in normal levels the expression of activation and inhibitory molecules, as well as a low proinflamatory environment that contributes to preservation of the immune function.
In conclusion, a reduced proportion of immune cells expressing activation and inhibitory molecules may contribute to the inhibition of HIV-1 infection in those individuals exposed to the virus, or with the control of viral replication in infected patients with low or undetectable viral load, as they can respond effectively, reducing the risk of infection or AIDS progression. Finally, our data support the immune quiescence hypothesis in HESN and expand it to disease control.
